|
|
| |
| |
T002: Phase II therapeutic trial with HIV-1 Tat vaccine candidate |
|
|
| T002, the Phase II therapeutic trial with HIV-1 Tat vaccine candidate has been approved by the ethical committees of the participating clinical centers. The treatment phase of the enrolled patients is currently ongoing. Specific information about T002 can be accessed from the links below. |
| |
| T002 Section Index. |
| What is T002 |
| Participating clinical centers |
| Protocol synopsis |
| Advisory Boards |
|
|
|
|
|
|
|
